Neuro-Oncology News

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

Insurance and neighborhood socioeconomic status were significant mediators of inequity in CV mortality among Black and white cancer survivors, according to a study published in the International Journal of Epidemiology.

Today is Glioblastoma Awareness Day.

Ashley Sumrall, MD, FACP, has had a passion for fighting for patients outside of the exam room for as long as she can remember.

Falls in an inpatient cancer rehabilitation unit occurred less frequently than previous studies have estimated and usually caused patients no harm, according to data published in JCO Oncology Practice.

The FDA announced several regulatory actions the past few weeks.

Nearly 7,000 abstracts had been submitted for presentation at this year’s ASCO Annual Meeting.

ASCO Chief Medical Officer Julie R. Gralow, MD, FACP, FASCO, urged members of Congress to take action on cancer drug shortages, which she described as the worst she has witnessed during her 30-year career in oncology.

CHICAGO — Healio | HemOnc Today gathered the best, brightest and boldest in oncology for its second annual Disruptive Innovators Awards.

CHICAGO — Vorasidenib significantly improved PFS while delaying time to next intervention among certain patients with grade 2 isocitrate dehydrogenase 1- or 2-mutant glioma, according to data presented at ASCO Annual Meeting.